GlassScriptPhysician profile
Thomas W Dooley
NPI 1760464754
$1,225.42
in general payments reported to CMS, 2019-2025
13 companies · $442 in 2025
The $442 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $300 · 2020: $54.38 · 2021: $138 · 2022: $71.86 · 2023: $142 · 2024: $76.51 · 2025: $442.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $661.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $660.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $333.65 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander, Mentor Cpx 2 Breast Tissue Expander |
| Aroa Biosurgery Incorporated | $291.24 | 2025 | |
| Sientra, INC. | $173.99 | 2020-2021 | |
| Allergan, INC. | $151.53 | 2019-2022 | |
| Lifenet Health | $71.86 | 2023-2024 | Theragenesis Wound Matrix |
| Musculoskeletal Transplant Foundation INC. | $54.92 | 2019-2022 | |
| Integra Lifesciences Corporation | $30.90 | 2019 | |
| Urgo Medical North America, LLC | $24.09 | 2023 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2 |
| Solventum Corporation | $22.54 | 2024 | Activ.A.C. |
| Osiris Therapeutics INC. | $20.52 | 2019 | |
| Kci USA, INC. | $18.47 | 2023 | Kerramax Care, Activ.A.C., Promogran Prisma |
| Galderma Laboratories, L.P. | $17.65 | 2025 | Nemluvio |
| Axogen | $14.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Dooley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.